Skip to main content
. 2014 May 27;111(23):8649–8654. doi: 10.1073/pnas.1323920111

Fig. 4.

Fig. 4.

Differential effects of ketamine and memantine on eEF2 phosphorylation and BDNF protein expression at three different time points following treatment. (A and C) Densitometric analysis of phosphorylated eEF2 (P-eEF2) levels revealed ketamine caused a significant decrease in the ratio of P-eEF2/total eEF2 (T-eEF2) at 30 min, whereas memantine (3 mg/kg and 10 mg/kg) did not have an impact on phosphorylation of eEF2. [ANOVA: F3,44= 3.579, *P = 0.021; Tukey’s post hoc analysis: saline vs. ketamine, *P = 0.018; saline vs. 3 mg/kg memantine, P = 0.569; saline vs. 10 mg/kg memantine, P = 0.930 (n = 10–13 per group)]. (B and D) Densitometric analysis of BDNF levels revealed that memantine did not have a significant effect on BDNF protein expression 30 min after injection; however, ketamine treatment caused a significant increase in BDNF protein [ANOVA: F3,49 = 5.893, P = 0.0016; Tukey’s post hoc analysis: saline vs. ketamine, *P = 0.02; saline vs. 3 mg/kg memantine, P = 0.999; saline vs. 10 mg/kg memantine, P = 0.745 (n = 12–15 per group)]. (E and G) Neither ketamine nor memantine caused a significant change in the levels of P-eEF2 8 h after injection, as shown by densitometric analysis (ANOVA: F3,21 = 0.0828, P = 0.969). (F and H) There was no change in the amount of BDNF protein in the hippocampus 8 h following injection with ketamine or memantine (ANOVA: F3,24 = 1.006, P = 0.407). (I and K) Densitometric analysis of P-eEF2 levels showed no difference in P-eEF2/T-eEF2 between saline and ketamine or memantine treatment 24 h after injection (ANOVA: F3,16 = 0.731, P = 0.552). (J and L) Densitometric analysis of BDNF protein showed no difference between saline, ketamine, or memantine treatment 24 h following injection (ANOVA: F3,25 = 0.206, P = 0.891). p/t, phospho/total.